Option Care Health (NASDAQ:OPCH) Sees Large Volume Increase – Here’s Why

Option Care Health, Inc. (NASDAQ:OPCH) saw strong trading volume on Thursday. 4,789,888 shares traded hands during trading, an increase of 63% from the average daily volume of 2,933,298 shares. The stock last traded at $31.6850 and had previously closed at $31.29.

Analyst Upgrades and Downgrades

A number of equities analysts recently issued reports on OPCH shares. Weiss Ratings raised shares of Option Care Health from a “hold (c-)” rating to a “hold (c)” rating in a research report on Tuesday, October 20th. Jefferies Financial Group lowered Option Care Health from a “buy” rating to a “hold” rating and raised their price target for the stock from $28.00 to $32.05 in a research report on Tuesday, October 6th. Truist Financial set a $32.05 price objective on Option Care Health in a research note on Wednesday, October 7th. Morgan Stanley set a $32.05 target price on Option Care Health in a research report on Monday, October 12th. Finally, UBS Group cut Option Care Health from a “buy” rating to a “neutral” rating and lowered their price target for the company from $39.00 to $32.05 in a research note on Friday, October 9th. Two research analysts have rated the stock with a Buy rating and fourteen have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $29.48.

Option Care Health Price Performance

The company has a 50-day moving average of $26.17 and a 200-day moving average of $26.47. The company has a debt-to-equity ratio of 0.91, a quick ratio of 0.98 and a current ratio of 1.47. The firm has a market capitalization of $4.77 billion, a price-to-earnings ratio of 23.97, a price-to-earnings-growth ratio of 1.90 and a beta of 0.58.

Option Care Health (NASDAQ:OPCH) last issued its quarterly earnings data on Wednesday, July 29th. The company reported $0.45 EPS for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The business had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.42 billion. Option Care Health had a net margin of 3.68% and a return on equity of 18.74%. The firm’s quarterly revenue was up 1.9% on a year-over-year basis. During the same period last year, the business posted $0.41 earnings per share. As a group, research analysts anticipate that Option Care Health, Inc. will post 1.70 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in OPCH. Vise Technologies Inc. lifted its holdings in Option Care Health by 88.7% during the third quarter. Vise Technologies Inc. now owns 20,516 shares of the company’s stock valued at $461,000 after purchasing an additional 9,646 shares during the last quarter. Choreo LLC bought a new position in shares of Option Care Health during the third quarter valued at approximately $419,000. VestGen Advisors LLC bought a new stake in Option Care Health in the 3rd quarter worth about $220,000. Leeward Investments LLC MA grew its stake in shares of Option Care Health by 20.1% during the 3rd quarter. Leeward Investments LLC MA now owns 848,059 shares of the company’s stock valued at $19,073,000 after purchasing an additional 142,007 shares during the period. Finally, Sterling Capital Management LLC boosted its holdings in shares of Option Care Health by 361.7% during the 3rd quarter. Sterling Capital Management LLC now owns 4,866 shares of the company’s stock valued at $109,000 after purchasing an additional 3,812 shares during the last quarter. Institutional investors own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health, Inc is an independent provider of home and alternate-site infusion services in the United States. The company coordinates and delivers infusion therapy outside traditional hospital settings, including patients’ homes, ambulatory infusion suites and other outpatient locations.

Its services include administration of anti-infective therapies, immune globulin, nutrition support, inotropic therapies and medications used in the treatment of chronic and complex conditions.